Journey Medical Balance Sheet Health
Financial Health criteria checks 5/6
Journey Medical has a total shareholder equity of $20.4M and total debt of $17.6M, which brings its debt-to-equity ratio to 86.6%. Its total assets and total liabilities are $76.8M and $56.5M respectively. Journey Medical's EBIT is $1.1M making its interest coverage ratio 0.8. It has cash and short-term investments of $27.4M.
Key information
86.6%
Debt to equity ratio
US$17.62m
Debt
| Interest coverage ratio | 0.8x |
| Cash | US$27.44m |
| Equity | US$20.35m |
| Total liabilities | US$56.50m |
| Total assets | US$76.85m |
Recent financial health updates
Recent updates
Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%
Mar 11
Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues
Jan 18Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Nov 10US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results
May 12Financial Position Analysis
Short Term Liabilities: DERM's short term assets ($56.5M) exceed its short term liabilities ($41.9M).
Long Term Liabilities: DERM's short term assets ($56.5M) exceed its long term liabilities ($14.6M).
Debt to Equity History and Analysis
Debt Level: DERM has more cash than its total debt.
Reducing Debt: Insufficient data to determine if DERM's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable DERM has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: DERM is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 28.4% per year.